Screener
Insulet PODD EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Insulet’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
| (in millions, except share and per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income tax expense | (23.7) | (5.9) | (45.6) | (18.6) |
| Net income | $95.0 | $22.5 | $186.1 | $57.9 |
| Earnings per share: | ||||
| Basic | $1.37 | $0.32 | $2.67 | $0.82 |
| Diluted | $1.37 | $0.32 | $2.67 | $0.82 |
| Weighted-average number of common shares outstanding (in thousands): | ||||
| Basic | 69,298 | 70,389 | 69,642 | 70,330 |
| Diluted | 69,403 | 70,652 | 69,803 | 70,641 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Insulet's EPS (diluted)?
- Insulet (PODD) reported EPS (diluted) of $1.37 in Q2 2026.
- How has Insulet's EPS (diluted) changed year-over-year?
- Insulet's EPS (diluted) increased by 328.1% year-over-year, from $0.32 to $1.37.
- What is the long-term trend for Insulet's EPS (diluted)?
- Over 4 years (2021 to 2025), Insulet's EPS (diluted) has grown at a 97.4% compound annual growth rate (CAGR), from $0.23 to $3.49.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Insulet's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude